The effect of interferons on vesicular stomatitis virus (VSV) primary transcription, amplified RNA synthesis [i.e. the sum of primary transcription RNA replication (leading to [-] RNA) and secondary transcription (leading to [+ ] RNA) and virus protein synthesis were studied. In a human cell line, both human and simian interferons inhibited the initiation of primary transcription and amplified RNA synthesis. In contrast, in a simian cell line tested similarly, the initiation of these activities was not affected, though they decreased as the infection progressed. Nevertheless, virus protein synthesis was completely inhibited. These results demonstrate that the action of interferon on virus transcription and/or translation may depend more on the host cell than on the particular interferon used.
There is considerable controversy at present regarding the primary site of action of interferon and two main, but not mutually exclusive, hypotheses have been proposed. The first postulates that interferon-induced antiviral protein(s) act at the level of translation of virus messenger (m) RNA (Joklik & Merigan, 1966; Metz & Esteban, I972; Repik et al. 1974; Wiebe & Joklik, I975; Samuel, 1976) . The second hypothesis states that interferon acts at the transcriptional level (Marcus et aL I97I; Oxman & Levin, 197I; Manders et aL 1972;  Yamamoto et al. I975; Metz et al. I976) . Recently, Baxt et al. (I977) reported that the primary effect of homologous interferon in human amnion and monkey kidney cell lines was on the translation of VSV mRNA as shown by inhibition of virus protein synthesis despite the apparent presence of nearly normal amounts of virus mRNA. In contrast, Manders et aL (1972) showed that in human muscle skin fibroblast cells treated with homologous interferon, VSV primary transcriptase activity was inhibited by 85 %. More recently, Marcus & Sekellick (I978) found that in green monkey kidney (Vero) cells infected with the VSV ts mutant G 4 I, human interferon led to a 7o % inhibition of primary transcription at 6 h after infection. In view of these apparent contradictions regarding the mechanism of action of interferon, experiments were conducted to study the effect of human and simian interferon in homologous and heterologous cell cultures on VSV primary and amplified RNA synthesis and on the translation of virus mRNA into specific VSV proteins.
Human foetal tonsil (FT) and African green monkey kidney (BGM) cells were grown in Eagle's minimal essential medium (MEM) containing lO % foetal calf serum. The Indiana strain of VSV was grown in mouse L cells (clone 929) with low multiplicity of infection (m.o.i.), and its infectivity assayed by plaque-formation on primary chick embryo (CE) cell monolayer (Youngner et al. 1966) . Human and simian interferons were prepared in HEp-z and BGM cells, respectively, using Newcastle disease virus (NDV) as the inducer (Hallum et aL 197o; Thacore, 1976) . Human and simian interferons were assayed on human foreskin (HF) or on BGM cell cultures by the semi-micro assay procedure of Armstrong (I971), with VSV as the challenge virus. There was no significant difference in the titre obtained for a human or a simian interferon when titrated on HF or BGM cells. With the procedure used for assay, the National Institutes of Health Human Reference Interferon (G-o23-9oi-527), with an assigned potency of 2oo0o units, had a mean titre of 35o0o units.
To study the effect of interferon on VSV RNA synthesis, FT cell monolayers (z x IO 6 cells) were pre-treated with medium or with IOOO units of human or simian interferon for 24 h at 37 °C. This concentration of either interferon inhibited the single cycle yield of VSV by about IOOOO-fold. The control and interferon treated cultures were infected with VSV at an input m.o.i, of 2oo in the presence of Io #g/ml of actinomycin D. After 45 rain, at 37 °C, the cultures were washed with medium and re-fed with medium containing Io/~g/ml 3H-uridine (sp. act. 25 Ci/mmol), and re-incubated at 37 °C. At various periods of time aeid-precipitable radioactivity was determined (Thacore & Youngner, I975) .
Primary transcription mediated by the virion-bound polymerase was also determined in vivo in interferon-treated and control cultures in the presence of actinomycin D at Io #g/ml and cycloheximide (CH) at 2oo #g/ml, as described by Marcus et al. 097~) . The results presented in Fig. I (a) show that in control non-interferon treated cells, the VSV transcriptase activity was detected between r and 2 h after infection, and transcripts continued to accumulate during the next 4 h after infection. In contrast, in cells pre-treated with either human or simian interferon, no primary transcriptase activity was detected, which suggests that the initiation of the VSV primary transcription was completely inhibited. These results differ from those reported with other human cells (Manders et aL I972; Baxt et aL x977) in that interferon completely inhibited the initiation of primary transcription in FT cells. The effect of interferon on VSV amplified RNA synthesis, i.e. that measured in the presence of actinomycin D but absence of CH, is shown in Fig. ~ (b) . In control cells, this synthesis was detected between I and 2 h after infection and increased markedly during the next 4 h. In contrast, the synthesis of VSV RNA in interferon treated cells was almost completely inhibited. It is important to note that cultures treated with either human or simian interferon were as capable of incorporating 3H-uridine as non-interferon treated control cultures.
Similar experiments were conducted in BGM cells and the results are presented i1~ Fig. I (c) and (d) . In control cultures, the accumulation of VSV primary transcripts increased rapidly I h after infection and continued to accumulate up to 5 h after infection. In cultures pre-treated with human interferon, the initiation of primary transcription was not affected; however, there was a slight decrease in the initial rate of primary transcript accumulation during the first 2 h. During the next 3 h, the accumulation of these transcripts was significantly reduced and by about 5 h after infection the accumulation was 4o % of that found in control cell cultures. Similarly in cells pre-treated with simian interferon, the initiation of primary transcription was unaffected but the initial rate of accumulation of primary transcripts was significantly less than in control or human interferon treated cultures. The peak accumulation at 4 h after infection was about 35 % of the amount in control cultures (Fig. I c) . The effect of interferon on VSV amplified RNA synthesis is shown in Fig. I (d) . In control cultures, VSV RNA synthesis was detected I to 2 h after infection and continued to increase markedly up to 5 h after infection. In cultures pre-treated with either human or simian interferon, the initiation of VSV amplified RNA synthesis was unaffected, and the accumulation of ~H-uridine counts was similar to that in control cells up to 2 h after infection. However, by 4 and 5 h after infection, VSV amplified RNA synthesis was significantly reduced and was only about 4o to 6o % of the control level in human interferon treated cell cuRures and 3o to 40 % of the control level in cultures pre-treated with simian interferon. These results indicate that in BGM cells, interferon pre-treatment did not affect the time of initiation of VSV primary transcription or amplified RNA synthesis, but as the infection progressed the accumulation of primary transcripts as well as the amplified synthesis was markedly reduced.
Further experiments were conducted to determine if VSV directed proteins were synthesized in interferon treated FT and BGM cells under the experimental conditions described above. Control and interferon treated cell cultures were infected with VSV at an input m.o.i, of 2oo. At 4"5 h after infection, cultures were washed three times with Hank's basal salt solution (HBSS) and re-fed with I ml of HBSS containing I5/zCi/ml of l~C-protein hydrolysate. After 4o min incubation at 37 °C, the monolayers were washed again three times with phosphate buffered saline (PBS), pH 7.z, and cells from each culture were suspended in o'5 ml of tris-HC1 buffer, pH 7"4. Each cell suspension was subjected to sonication before storage at -7 ° °C. The proteins were separated by sodium dodecyl The gel slabs were composed of a 7"5 % resolving gel and a 3"5 % stacking gel. All samples were treated with t % SDS, 4 M-urea and Io % 2-mercaptoethanol and put in boiling water for 1.5 rain. Samples were cooled, mixed with glycerol and put in slots and electrophoresis was carried out at 20 mA/slab until the tracing dye (bromophenol blue) reached the bottom of the slab. The gel slab was then removed from the cell and dried under heat and vacuum with a gel slab drier, and autoradiograms were prepared using a Kodak no-screen X-ray film. The autoradiograms were cut into strips and scanned for absorbance at 56o nm with an ISCO absorbance monitor assisted by a slab gel scanner. Purified VSV (B particle) proteins and VSV glycoproteia (G) were used as markers and included in one slot of each slab. Commercially prepared bovine serum albumin, ovalbumin, pepsin and ribonuclease were also used as markers. The densitometer tracings of the autoradiograms of the polypeptides synthesized ia FT and BGM cells infected with VSV in the presence or absence of interferon are shown in Fig. 2 . With FT cells (Fig. 2a ) the four main VSV polypeptides (L, G, N and M; Wagner et al. i972) were synthesized in control cultures with virtually complete inhibition of host protein synthesis (Fig. 2a, panel I ). In contrast, the densitometer tracing profile of polypeptides in cells pre-treated with either human (Fig. 2a, panel 2 ) or simian (panel 3) interferon was similar to that from uninfected control cells (panel 4) which suggests that no detectable VSV proteins were synthesized in interferon treated cells. These results were not unexpected since, under these experimental conditions, virus mRNA synthesis was also not detected ( Fig. I a, b) . Very similar results were obtained in BGM cells (Fig. 2b) in spite of the fact that there was a significant amount of primary transcription and VSV amplified RNA synthesis in human or simian interferon treated cell cultures. The densitometer tracings show that the four main VSV polypeptides were synthesized in control cultures with complete inhibition of cellular protein synthesis (Fig. 2 b, panel I) . The tracing profiles of p olypeptides in cultures pre-treated with human ( Fig. 2b, panel 2 ) or simian (panel 3) interferon were similar to that of the uninfected control culture (panel 4), indicating that in interferon treated cells the translation of VSV mRNA was inhibited. With respect to the inhibition of virus protein synthesis, these results confirm the findings of Baxt et al. 0977) , and suggest that in BGM ceils mRNA synthesis mediated by primary transcription is less sensitive to interferon action than the posttranscriptional step involving protein synthesis.
The results presented above demonstrate that the host cell can play an important role in determining the effect of interferon on VSV primary transcription and/or translation. In FT cells pre-treated with human or simian interferon, there was no detectable accumulation of primary transcripts. Also in these same cells, neither amplified RNA synthesis nor virus protein synthesis could be detected, further confirming that the initiation of primary transcription was inhibited. These results are in agreement with the report of Marcus & Sekellick (~ 978) , who suggested that human interferon blocks the initiation of transcription of a VSV ts mutant G4I in Vero cells in the presence of CH. In BGM cells under similar experimental conditions, the initiation of primary transcription was not affected; however, significantly fewer transcripts accumulated in interferon-treated cultures than in the control cultures. Similarly, the initiation of amplified RNA synthesis in the absence of CH was unaffected in interferon-treated cells, but the amount of RNA synthesized late in infection was significantly reduced. However, no VSV proteins were detected in interferon-treated cells, suggesting that the translation of virus mRNA was inhibited. These results are similar to those obtained in other simian cell lines with human or simian interferon (Baxt et al. I977; Marcus & Sekellick, r978 ) .
It is difficult to draw definite conclusions regarding the site of action of interferon in simian cells, where there is only partial inhibition of primary transcription. These VSV primary transcripts that do accumulate in interferon-treated cells appear to be normal and are not significantly degraded (Marcus & Sekellick, 1978) ; this and other studies suggest that in such cells a post-transcriptional step may be more sensitive to inhibition by interferon than primary transcription.
In conclusion, the mode of action of interferon may be governed by the host cell rather than the interferon used to induce the resistance. This work was supported by Public Health Service grant 5o-E I29 D. 
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